Showing results (131-140 of 172) with videos related to
Sort By:
Pageof 18
Nature Medicine|January 13, 2026
Linavonkibart and pembrolizumab in immune checkpoint blockade-resistant advanced solid tumors: a phase 1 trialTimothy A Yap, Randy F Sweis, Ulka Vaishampayan, et al.Journal of Oncology Research and Therapy|March 14, 2025
Differences in Co-Expression of T Cell Co-Inhibitory and Co-Stimulatory Molecules with PD-1 Across Different Human CancersAhmad A Tarhini, Dale Hedges, Aik Choon Tan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2018
Phase Ib/II Study of Pembrolizumab and Pegylated-Interferon Alfa-2b in Advanced MelanomaDiwakar Davar, Hong Wang, Joe-Marc Chauvin, et al.Journal of Neurosurgery|October 29, 2013
The accuracy of predicting survival in individual patients with cancerDouglas Kondziolka, Phillip V Parry, L Dade Lunsford, et al.Journal for Immunotherapy of Cancer|January 14, 2026
Neoadjuvant lenvatinib plus pembrolizumab in Merkel cell carcinoma: an investigator-initiated, open-label phase II trialAndrew S Brohl, Vernon K Sondak, Evan J Wuthrick, et al.JCO Precision Oncology|May 5, 2025
Training, Validating, and Testing Machine Learning Prediction Models for Endometrial Cancer RecurrenceJesus Gonzalez Bosquet, Andrew Polio, Erin George, et al.Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|August 27, 2022
Patient-reported tolerability of adjuvant ipilimumab (3 or 10 mg/kg) versus high-dose interferon alfa-2b for resected high-risk stage III-IV melanoma in phase III trial E1609Laurie E McLouth, Yue Zheng, Stephanie Smith, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 17, 2024
Neoadjuvant Intratumoral Plasmid IL-12 Electro-Gene-Transfer and Nivolumab in Patients with Operable, Locoregionally Advanced MelanomaAhmad A Tarhini, Zeynep Eroglu, Islam Eljilany, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2022
Single-cell Characterization of the Cellular Landscape of Acral Melanoma Identifies Novel Targets for ImmunotherapyJiannong Li, Inna Smalley, Zhihua Chen, et al.Nature Communications|November 13, 2025
Multicellular immune ecotypes within solid tumors predict real-world therapeutic benefits with immune checkpoint inhibitorsXuefeng Wang, Tingyi Li, Islam Eljilany, et al.Pageof 18